India  

Covaxin has 81% interim vaccine efficacy - here's what it means

DNA Thursday, 4 March 2021
The trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: 'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech

'COVAXIN' demonstrated efficacy of 80.6% in Phase 3 clinical trial: Bharat Biotech 01:42

Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The...

You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Related videos from verified sources

Sonia Gandhi asks Centre to lower COVID-19 vaccine age eligibility to 25 [Video]

Sonia Gandhi asks Centre to lower COVID-19 vaccine age eligibility to 25

As the COVID-19 pandemic continues to rage across the country, Congress interim president Sonia Gandhi asked Centre to lower the COVID vaccine age eligibility to 25 and above. "India has already..

Credit: ANI     Duration: 01:04Published
Pfizer CEO Says 3rd Dose of COVID-19 Vaccine Is ‘Likely’ Needed [Video]

Pfizer CEO Says 3rd Dose of COVID-19 Vaccine Is ‘Likely’ Needed

Pfizer CEO Says 3rd Dose of COVID-19 Vaccine Is ‘Likely’ Needed. On April 15, Pfzier’s CEO, Albert Bourla, spoke about the future of COVID-19 vaccinations at a CVS Health event. . According..

Credit: Wibbitz Top Stories     Duration: 01:05Published
Clearing Up Confusion About Safety And Efficacy Of Johnson & Johnson COVID Vaccine [Video]

Clearing Up Confusion About Safety And Efficacy Of Johnson & Johnson COVID Vaccine

There have been reports of vaccinated people getting COVID and concerns over the supply and effectiveness of the Johnson & Johnson vaccine. CBS2's Dr. Max Gomez reports.

Credit: CBS 2 New York     Duration: 02:11Published

Related news from verified sources

Iran to get 5,00,000 doses of Covaxin, first tranche sent already

Next week the country will receive 3,75,000 doses of Covaxin from India as part of the second such consignment.
DNA Also reported by •IndiaTimesZee News

Chief Minister, Health Minister get vaccinated

Both of them took Covaxin, India’s indigenous COVID-19 vaccine developed by Hyderabad-based Bharat Biotech
Hindu Also reported by •IndiaTimes

PM Modi sends out key message as he takes Covaxin shot

Prime Minister Narendra Modi was administered the first dose of Covid-19 vaccine on Monday. Among the two vaccines available in India, PM Modi was administered...
IndiaTimes